Prong joined Complement Therapeutics in late 2022, bringing a multidisciplinary background across biotechnology, clinical research and early-stage ventures. She holds a degree in Bioprocessing of New Medicines from University College London and a degree in Innovation, Entrepreneurship and Management from Imperial College London.

Prior to joining Complement Therapeutics, she gained experience in start-ups spanning food biotechnology, digital commerce and Thailand’s first national clinical research organisation. At Complement Therapeutics, she helps translate programme strategy into effective execution to support the delivery of high-quality clinical studies.